封面
市场调查报告书
商品编码
1447641

血流动力学监测设备市场- 按产品(一次性用品、监测仪)、系统类型(侵入式、微创式、非侵入式)、最终用途(医院、门诊手术中心、家庭护理机构) - 全球预测2024 - 2032

Hemodynamic Monitoring Devices Market - By Product (Disposables, Monitors), System Type (Invasive, Minimally Invasive, Non-invasive), End-use (Hospitals, Ambulatory Surgical Centers, Homecare Settings) - Global Forecast 2024 - 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 114 Pages | 商品交期: 2-3个工作天内

价格
简介目录

由于对患者血流动力学状态持续监测的需求不断增长,2024 年至 2032 年间,全球血流动力学监测设备市场规模将达到 5.9% 的CAGR。医疗机构越来越认识到即时监测对于改善患者治疗结果的好处。加上无线连接和增强的准确性等技术进步,这些设备提供了更有效率、用户友好的解决方案。

新型创新血液动力学监测设备的推出将进一步推动市场扩张,以满足医疗保健环境中对复杂监测工具不断增长的需求。例如,2023年4月,Vygon India推出了Mostcare Up,这是一种先进的血流动力学监测系统。这种基于微创动脉压的监测仪利用基于压力记录分析方法 (PRAM) 的专利演算法来即时监测细微的血流动力学变化。

血液动力学监测设备市场分为产品、系统类型、最终用途和区域。

就係统类型而言,由于人们越来越青睐微创手术以提供缩短康復时间和缩短住院时间等好处,因此到 2032 年,微创领域的行业规模将实现 5.9% 的增长率。血流动力学监测设备透过提供患者心血管状况的即时资料在这些手术中发挥着至关重要的作用。此外,技术进步催生了越来越便携和用户友好的监测设备,从而加速了它们在微创外科手术中的采用。

根据最终用途,门诊手术因其成本效益和便利性而日益增长,这推动了门诊手术中心市场的血流动力学监测设备市场到 2032 年将实现 5.8% 的CAGR。门诊手术中心 (ASC) 正在采用血流动力学监测设备来确保患者安全并优化手术结果。不断进步的技术也使得这些设备更加紧凑,并且对于 ASC 设定来说更加用户友好。

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 全球慢性病发生率上升
      • 血流动力学监测设备的技术进步
      • 越来越多地采用远端血流动力学监测设备
      • 人们越来越喜欢远距医疗服务
    • 产业陷阱与挑战
      • 病患监护设备成本高
      • 严格的监管框架
  • 成长潜力分析
  • 监管环境
  • 技术景观
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 公司市占率分析
  • 竞争定位矩阵

第 5 章:市场估计与预测:按产品分类,2018 年 - 2032 年

  • 主要趋势
  • 免洗用品
  • 显示器

第 6 章:市场估计与预测:按系统类型,2018 年 - 2032 年

  • 主要趋势
  • 非侵入性
  • 侵入性
  • 微创

第 7 章:市场估计与预测:按最终用途,2018 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 家庭护理设置
  • 其他最终用户

第 8 章:市场估计与预测:按地区划分,2018 年 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 亚太地区其他地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地区
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿联酋
    • 中东和非洲其他地区

第 9 章:公司简介

  • Becton, Dickinson and Company
  • Baxter International Inc.
  • Deltex Medical Group PLC
  • Edwards Lifesciences Corporation
  • GE HealthCare
  • ICU Medical, Inc.
  • Koninklijke Philips N.V.
  • Masimo Corporation
  • Medtronic plc
  • Nihon Kohden Corporation
  • OsypkaCardiotek GmbH
  • Siemens Healthineers AG
  • Sramek BioDynamics, Inc.
简介目录
Product Code: 7995

Global Hemodynamic Monitoring Devices Market size will register a 5.9% CAGR between 2024 and 2032, attributed to the rising demand for continuous monitoring of the hemodynamic status of patients. Healthcare facilities are increasingly recognizing the benefits of real-time monitoring for improving patient outcomes. Coupled with technology advancements, such as wireless connectivity and enhanced accuracy, these devices offer more efficient and user-friendly solutions.

The introduction of new and innovative hemodynamic monitoring devices will further propel the market expansion for catering to the rising need for sophisticated monitoring tools in healthcare settings. For instance, in April 2023, Vygon India introduced Mostcare Up, an advanced hemodynamic monitoring system. This minimally invasive arterial pressure-based monitor utilizes a patented algorithm based on the Pressure Recording Analytical Method (PRAM) for real-time monitoring of subtle hemodynamic variations.

The hemodynamic monitoring devices market is segmented into product, system type, end-use, and region.

With respect to system type, the industry size from the minimally invasive segment will witness 5.9% growth rate through 2032 due to the increasing preference for minimally invasive procedures to offer benefits, such as reduced recovery time and shorter hospital stays. Hemodynamic monitoring devices play a crucial role in these procedures by providing real-time data on a patient's cardiovascular status. Furthermore, technological advancements have resulted in the creation of monitoring devices that are increasingly portable and user-friendly, thereby accelerating their adoption in minimally invasive surgical procedures.

Based on end-use, the hemodynamic monitoring devices market from the ambulatory surgical centers segment will garner 5.8% CAGR up to 2032, driven by the increasing trend towards outpatient surgeries due to their cost-effectiveness and convenience. Ambulatory surgical centers (ASCs) are adopting hemodynamic monitoring devices to ensure patient safety and optimize surgical outcomes. Rising technological advancements have also made these devices more compact and user-friendly for ASC settings.

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definitions
  • 1.2 Base estimates & calculations
  • 1.3 Data collection
  • 1.4 Forecast parameters
  • 1.5 Data sources
    • 1.5.1 Primary
    • 1.5.2 Secondary
      • 1.5.2.1 Paid sources
      • 1.5.2.2 Unpaid sources

Chapter 2 Executive Summary

  • 2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising incidence of chronic diseases across the globe
      • 3.2.1.2 Technological advancements in hemodynamic monitoring devices
      • 3.2.1.3 Growing adoption of remote hemodynamic monitoring devices
      • 3.2.1.4 Growing preference for telehealth services
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 High cost of patient monitoring devices
      • 3.2.2.2 Stringent regulatory framework
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Technological landscape
  • 3.6 Porter's analysis
    • 3.6.1 Supplier power
    • 3.6.2 Buyer power
    • 3.6.3 Threat of new entrants
    • 3.6.4 Threat of substitutes
    • 3.6.5 Industry rivalry
  • 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Company market share analysis
  • 4.4 Competitive positioning matrix

Chapter 5 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Disposables
  • 5.3 Monitors

Chapter 6 Market Estimates and Forecast, By System Type, 2018 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Non-invasive
  • 6.3 Invasive
  • 6.4 Minimally invasive

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Hospitals
  • 7.3 Ambulatory surgical centers
  • 7.4 Homecare settings
  • 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 France
    • 8.3.4 Italy
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 South Korea
    • 8.4.6 Rest of Asia Pacific
  • 8.5 Latin America
    • 8.5.1 Brazil
    • 8.5.2 Mexico
    • 8.5.3 Argentina
    • 8.5.4 Rest of Latin America
  • 8.6 Middle East and Africa
    • 8.6.1 South Africa
    • 8.6.2 Saudi Arabia
    • 8.6.3 UAE
    • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

  • 9.1 Becton, Dickinson and Company
  • 9.2 Baxter International Inc.
  • 9.3 Deltex Medical Group PLC
  • 9.4 Edwards Lifesciences Corporation
  • 9.5 GE HealthCare
  • 9.6 ICU Medical, Inc.
  • 9.7 Koninklijke Philips N.V.
  • 9.8 Masimo Corporation
  • 9.9 Medtronic plc
  • 9.10 Nihon Kohden Corporation
  • 9.11 OsypkaCardiotek GmbH
  • 9.12 Siemens Healthineers AG
  • 9.13 Sramek BioDynamics, Inc.